Medtronic (MDT) Revenue — Quarter Ended Oct 25, 2024
Revenue for the quarter rose compared to both the immediately preceding quarter and the same quarter one year earlier. The increase reflects higher net sales reported in the unaudited consolidated statements of income.
Key takeaway
Quarter ended Oct 25, 2024 · FY2025 Q2
Revenue for the quarter rose compared to both the immediately preceding quarter and the same quarter one year earlier. The increase reflects higher net sales reported in the unaudited consolidated statements of income.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$8.4B
Revenue reported for this quarter.
Quarter-over-quarter
+6.2%
Change from the immediately preceding quarter.
Year-over-year
+5.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$33B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jan 26, 2024 | $8.1B | +4.7% |
| Apr 26, 2024 | $8.6B | +0.5% |
| Jul 26, 2024 | $7.9B | +2.8% |
| Oct 25, 2024 | $8.4B | +5.2% |
Revenue performance
The reported revenue direction was upward, with net sales exceeding the prior quarter's figure. This marks a continuation of the positive trend observed in the most recent trailing twelve months.
Quarterly comparison
Compared to the immediately preceding quarter, revenue increased. Compared to the same quarter one year earlier, revenue also increased, maintaining year-over-year growth.
What to watch
The company's outlook is subject to competition in the medical device industry, as noted in the risk factors section of the filing.